Key Takeaways
- Resilient margins in a soft quarter: Gross margin expanded 60 bps to 70.7% despite persistent demand headwinds from food inflation and Bangladesh unrest, while the company reiterated its full-year commitment to high single-digit revenue growth and double-digit EBITDA growth.
- Kesh King is the big bet, but the payoff is distant: Management is committing disproportionate investment behind the struggling anti-hair fall brand, with BCG engaged to craft a strategy; results are not expected for 6–8 months, making this a FY26 story.
- Winter and rural recovery are the near-term catalysts: A strong winter forecast and rural demand running slightly ahead of urban set the stage for BoroPlus and pain management to drive Q3, with management expecting at least 7–8% growth in the quarter.
- Helios and The Man Company transitions are a drag now, a lever later: A one-off revenue decline from the Helios management transition and a CEO hire at The Man Company signal investment mode; both are expected to resume growth from Q3/Q4 onward.
- What to watch next quarter: Whether the promised winter-led BoroPlus uptick materializes, the pace of Helios recovery, and any early signals from the BCG-led Kesh King strategy work.
Demand & Revenue Drivers
- Mass consumer stress persisted: High food inflation continued to pressure mass-market consumers in Q2, keeping demand trends similar to the subdued Q1 and weighing on price-sensitive categories like Kesh King.
- Bangladesh disruption: Political unrest, rising inflation, and depleting forex reserves in a key international market created temporary hurdles; the situation improved from July/August lows but the business environment remains challenging.
- Winter loading delayed by design: BoroPlus winter-season loading was consciously pushed to October/November rather than September, aligning shipments with seasonal offtake and deferring some revenue to Q3.
- Rural slightly ahead of urban: Rural demand is running marginally better than urban, a tailwind for Q3 given BoroPlus antiseptic cream draws the majority of its sales from rural markets during winter.
- OTC channel broadening: Modern trade and quick-commerce platforms are increasing their participation in the OTC category, creating a new growth avenue the company intends to capitalize on as the landscape evolves.
Mohan Goenka: "Net, we expect at least 7% - 7% to 8% growth in this quarter."
Brand Portfolio: Bets & Turnarounds
Kesh King: the disproportionate bet
- BCG engaged for category revival: Work began in August on a growth strategy for Kesh King and BoroPlus; solutions are expected in 6–8 months, with implementation and results stretching the timeline further.
- Investment without immediate return: Management is prepared to spend any amount and will deploy disproportionate A&P behind Kesh King, citing strong conviction in the brand's potential despite its current drag on overall growth.
- Extensions in the pipeline: New extensions to Kesh King oil and a push on shampoo are planned, though the full strategic overhaul will take 1–2 quarters for BCG to deliver.
Mohan Goenka: "We will spend disproportionately on Kesh King because we are very, very bullish."
BoroPlus: winter-dependent, structurally diversifying
- Portfolio mix transformation: Five years ago, BoroPlus was 90–92% antiseptic cream; today that share is ~75%, with lotion, aloe vera gel and soap contributing 25% and reducing dependence on a single winter-season SKU.
- BoroPlus Soft re-launch: The light moisturizing cream was re-launched with a fresh look and is seen as a potential significant value driver for the broader BoroPlus portfolio.
- Winter sensitivity: A good winter could add 1–2% of additional growth; even in a normal winter, management expects 7–8% BoroPlus growth in H2, with a strong winter pushing that to high single or double digits.
Male Grooming: a re-launch bet
- Fair and Handsome repositioned: Re-launched in November with a young brand ambassador and packaging overhaul, moving the brand into the larger male grooming space rather than staying narrowly in fairness.
- HE brand re-launched: A complete male grooming re-launch under HE is being tested first on e-commerce; if momentum builds, it will expand into modern trade.
- Significant launches ahead: More new products are planned for Q4 or H1 of next fiscal year, with management hopeful the re-launch changes will begin showing growth this quarter or next.
Channel & Distribution Evolution
- GT delivered 11% growth: The general trade business, predominantly OTC and pharma/ayurvedic, drove the quarter's growth, supported by the now-completed Project Khoj rural expansion.
- Project Khoj declared complete: The 3–4 year initiative to build hub-and-spoke rural distribution has officially done its job; the company is now harvesting the benefits through a strengthened retail network and growing category market shares.
- E-comm and modern trade outperforming: These channels have grown faster than GT for several years and now account for 26% of sales, a milestone management highlights as proof that Emami has products suited to modern retail despite earlier skepticism.
- Quick-commerce investment mode: The company expects quick-commerce to accelerate over coming quarters and is investing in resourcing and attention to double down on the channel.
- Zandu Care portal plus marketplaces: The online business operates across three channels: the proprietary Zandu Care portal, other e-commerce marketplaces, and an extension into modern trade with a robust product portfolio.
Mohan Goenka: "If you would remember about 5, 6 quarters or 7, 8 quarters back, no one believed that Emami can do 26% from e-comm and modern trade, because people believed we don't have the products for modern trade and e-comm. But that's not true."
Subsidiaries & Acquisitions: Transition Mode
- Helios Lifestyles one-off decline: The acquisition of the balance stake triggered a management transition that caused a temporary revenue dip in Q2; the business is poised for strong H2 growth as the transition completes by mid-November.
- The Man Company CEO hired: Vikas Mittal joined as CEO approximately 10 days before the call, filling a leadership gap; management is hopeful the brand will start growing again in Q3.
- The Man Company ambition: The target is to scale sales to ₹300–350 crores over the next 3–4 years, with a channel mix weighted toward digital, e-commerce and modern trade, and substantial cost reductions redeployed into advertising.
- Transition acknowledged as inherently uncertain: Management conceded that any transition takes time and that precise outcomes are difficult to predict, without confirming whether the Helios disruption was fully anticipated.
Mohan Goenka: "Any transition, Nitin, takes a while. Of course, we plan before we do any transition, okay? But it is very, very difficult to know exactly what is going to happen."
Margins & Investment
- Gross margin expanded 60 bps to 70.7%: The expansion came despite a soft top-line environment, with H1 gross margin up 140 bps to 69.2%.
- A&P phasing, not cutting: H1 A&P grew 7.6% driven by re-launches; Q2 saw a cut but spending will be made up in Q3/Q4, with higher second-half A&P overall. Margins are still expected to expand for the full year.
- EBITDA margin commitment intact: Management reiterated the commitment to double-digit EBITDA growth for FY25, with second-half margin expansion continuing the H1 trend.
- Other income boosted by surplus funds: Higher interest income and mutual fund gains on liquid investments, driven by higher surplus funds versus last year, contributed to the bottom line in the normal course of business.
- Tax rate to remain low: The H1 average tax rate was ~9%; the full-year rate is expected to stay at 9–10% due to MAT credit availability.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Revenue growth | High single-digit revenue growth for FY25 | FY25 |
| EBITDA growth | Double-digit EBITDA growth for FY25 | FY25 |
| Q3 revenue growth | At least 7–8% growth | Q3 FY25 |
| BoroPlus H2 growth | 7–8% growth in normal winter; high single to double-digit if winter is strong | H2 FY25 |
| Helios recovery | Growth resuming after mid-November transition completion; Q4 better than Q2 and Q3 | Q3/Q4 FY25 |
| Kesh King strategy delivery | BCG to deliver growth strategy solutions | 6–8 months from August 2024 |
| The Man Company sales target | Scale to ₹300–350 crores | Next 3–4 years |
| Full-year tax rate | 9–10% due to MAT credit | FY25 |
| New launch contribution | ~1% of total revenue | FY25 |
Key Metrics
| Metric | Q2 FY25 |
|---|---|
| Consolidated revenue | ₹891 cr, +3% YoY |
| H1 FY25 consolidated revenue | ₹1,797 cr, +6% YoY |
| Domestic business revenue growth | +3% YoY |
| Gross margin | 70.7%, expanded 60 bps YoY |
| EBITDA | ₹250 cr, +7% YoY; margin expanded 110 bps |
| Profit before tax | ₹220 cr, +13% YoY; margin expanded 220 bps |
| Profit after tax | ₹213 cr, +19% YoY |
| H1 FY25 gross margin | 69.2%, expanded 140 bps YoY |
| H1 FY25 EBITDA | ₹467 cr, +10% YoY |
| H1 FY25 PAT | ₹365 cr, +16% YoY |
| Interim dividend | ₹4 per share, 400% for FY24 |
| International business revenue growth | +6% YoY in constant currency and INR terms; +12% excluding Bangladesh |
| H1 FY25 international business growth | +9% in constant currency, +8% in INR terms |
| Navratna and Dermicool growth | +10% YoY |
| Healthcare range growth | +11% YoY |
| Pain management range growth | +5% YoY |
| BoroPlus growth | +2% YoY |
| Kesh King growth | -9% YoY |
| Male Grooming growth | -13% YoY |
| Organized channels contribution to domestic business | 26.6%, increased 190 bps in H1; grew 14% |
| The Man Company revenue | ~₹180 cr annual run-rate; declined in Q2 due to management transition |
| Helios (digital brands) revenue growth | -9% YoY due to ownership transition |
| A&P spending growth | -5% YoY in Q2; H1 growth +7.6% |
| 7 Oils in One brand size | ~₹45 cr in domestic business |
| H1 FY25 effective tax rate | ~9%; full year expected 9–10% |